207 related articles for article (PubMed ID: 10982767)
1. Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis.
Dohi T; Fujihashi K; Kiyono H; Elson CO; McGhee JR
Gastroenterology; 2000 Sep; 119(3):724-33. PubMed ID: 10982767
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice.
Tozawa K; Hanai H; Sugimoto K; Baba S; Sugimura H; Aoshi T; Uchijima M; Nagata T; Koide Y
J Gastroenterol Hepatol; 2003 May; 18(5):578-87. PubMed ID: 12702051
[TBL] [Abstract][Full Text] [Related]
3. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses.
Dohi T; Fujihashi K; Rennert PD; Iwatani K; Kiyono H; McGhee JR
J Exp Med; 1999 Apr; 189(8):1169-80. PubMed ID: 10209035
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
6. Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.
Zuo L; Yuan KT; Yu L; Meng QH; Chung PC; Yang DH
World J Gastroenterol; 2014 Dec; 20(48):18316-29. PubMed ID: 25561798
[TBL] [Abstract][Full Text] [Related]
7. Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice.
Camoglio L; te Velde AA; de Boer A; ten Kate FJ; Kopf M; van Deventer SJ
Eur J Immunol; 2000 May; 30(5):1486-95. PubMed ID: 10820397
[TBL] [Abstract][Full Text] [Related]
8. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
9. IL-17/IFN-γ interactions regulate intestinal inflammation in TNBS-induced acute colitis.
Jin Y; Lin Y; Lin L; Zheng C
J Interferon Cytokine Res; 2012 Nov; 32(11):548-56. PubMed ID: 23030668
[TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid ameliorates trinitrobenzene sulfonic acid-induced colitis by shifting Th1 to Th2 profile.
Bai A; Lu N; Zeng H; Li Z; Zhou X; Chen J; Liu P; Peng Z; Guo Y
J Interferon Cytokine Res; 2010 Jun; 30(6):399-406. PubMed ID: 20187766
[TBL] [Abstract][Full Text] [Related]
11. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells treated by Trichinella spiralis muscle larval excretory/secretory products alleviate TNBS-induced colitis in mice.
Jin X; Yang Y; Bai X; Shi H; Zhang W; Zhang Z; Jia W; Lin J; Liu M; Liu X
Int Immunopharmacol; 2019 May; 70():378-386. PubMed ID: 30852293
[TBL] [Abstract][Full Text] [Related]
13. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.
Neurath MF; Fuss I; Kelsall BL; Presky DH; Waegell W; Strober W
J Exp Med; 1996 Jun; 183(6):2605-16. PubMed ID: 8676081
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
[TBL] [Abstract][Full Text] [Related]
15. Elimination of colonic patches with lymphotoxin beta receptor-Ig prevents Th2 cell-type colitis.
Dohi T; Rennert PD; Fujihashi K; Kiyono H; Shirai Y; Kawamura YI; Browning JL; McGhee JR
J Immunol; 2001 Sep; 167(5):2781-90. PubMed ID: 11509623
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis.
Boirivant M; Fuss IJ; Ferroni L; De Pascale M; Strober W
J Immunol; 2001 Mar; 166(5):3522-32. PubMed ID: 11207312
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath MF; Fuss I; Kelsall BL; Stüber E; Strober W
J Exp Med; 1995 Nov; 182(5):1281-90. PubMed ID: 7595199
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.
Kullberg MC; Rothfuchs AG; Jankovic D; Caspar P; Wynn TA; Gorelick PL; Cheever AW; Sher A
Infect Immun; 2001 Jul; 69(7):4232-41. PubMed ID: 11401959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]